Page last updated: 2024-11-01

nylidrin and Dementia

nylidrin has been researched along with Dementia in 2 studies

Nylidrin: A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.

Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cook, P1
James, I1
Jansen, W1

Reviews

1 review available for nylidrin and Dementia

ArticleYear
Cerebral vasodilators (second of two parts).
    The New England journal of medicine, 1981, Dec-24, Volume: 305, Issue:26

    Topics: Aged; Animals; Betahistine; Cerebrovascular Circulation; Cerebrovascular Disorders; Cinnarizine; Cli

1981

Trials

2 trials available for nylidrin and Dementia

ArticleYear
Cerebral vasodilators (second of two parts).
    The New England journal of medicine, 1981, Dec-24, Volume: 305, Issue:26

    Topics: Aged; Animals; Betahistine; Cerebrovascular Circulation; Cerebrovascular Disorders; Cinnarizine; Cli

1981
[Analysis of the efficiency of Gerigoa-depot in a double-blind study].
    Die Medizinische Welt, 1976, Jul-23, Volume: 27, Issue:30

    Topics: Aged; Clinical Trials as Topic; Delayed-Action Preparations; Dementia; Drug Combinations; Drug Evalu

1976